Project Grant R01HD115580
Award Date
8/9/24
Completion Date
4/30/29
Dollars Obligated
$2.1M
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Bloomington, MN 55425, USA
Similar Awards
This $249,276 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is funding a study on the real-world effectiveness of maternal respiratory syncytial virus (RSV) vaccination. RSV is a leading cause of lower respiratory tract infections in infants, contributing to 33 million episodes and 101,400 deaths annually. With no existing antiviral therapies or effective treatments,...
This $310,644 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award will support a mixed-methods study to identify determinants of parental hesitancy towards seasonal respiratory vaccines (SRVs) for children in the post-COVID-19 pandemic era. The key objectives are to: 1) determine factors influencing parental SRV hesitancy, 2) identify pediatricians'...
This federal Project Grant award in the amount of $694,528.00 was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award will support research on "The Learning and Educational Attainment of Preterm and At-Risk Infants" over a 5-year period from June 5, 2025 to February 28, 2030. The awardee is Kaiser Foundation Hospitals, a prominent non-profit healthcare provider...
The National Institute of Child Health and Human Development (NICHD) awarded a $171,728 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Weill Medical College of Cornell University to study the role of premature infant gut microbiome dysbiosis in mediating immune development and response to respiratory syncytial virus (RSV) infection. The research aims to define how the altered gut microbiome in premature infants impacts their ability to mount effective...
This $232,500 Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research to investigate the virologic determinants that lead to long-term, antiretroviral therapy-free control in infants with in utero HIV-1 infection. The research will create and analyze infectious molecular clones from the HIV-1 genomes of participants in the IMPAACT P1115 clinical trial,...
This $404,479 federal project grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to develop mechanistic insights into the kinetics of Fc receptor-mediated placental antibody transfer. The goal is to optimize maternal vaccine strategies to maximize newborn immunization against serious infections. The key products and services to be delivered under this 5-year grant...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop and test a novel intervention to improve routine vaccination of hospitalized children. The $220,000 award to Seattle Children's Hospital will fund a two-year project with the following key components: Engaging hospital stakeholders to co-develop the "Presumptively Initiating Vaccines and...
This $756,077 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports a 5-year research study to investigate the long-term immunologic, cardiovascular, metabolic, and neurocognitive outcomes in children and adolescents with perinatal HIV infection who have achieved viral suppression on long-term antiretroviral therapy. The research will assess...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research to investigate the impact of maternal inflammation and viral infection during pregnancy on the development and function of fetal gamma-delta (γδ) T cells. The award provides $783,611.06 in funding to the University of Vermont & State Agricultural College (UVM) from September 5, 2024 to...
The National Institute of Child Health and Human Development (NICHD) awarded a $493,409 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Oregon Health & Science University (OHSU) to investigate the role of the renin-angiotensin system (RAS) at the maternal-fetal interface. The key objectives are to determine the cell-specific contributions of the RAS protein ACE2 in the placenta and decidua, and to examine RAS gene expression, protein abundance, and...